Literature DB >> 12081168

Outreach health adviser in a community clinic screening programme improves management of genital chlamydia infection.

K Jones1, A Webb, H Mallinson, H Birley.   

Abstract

OBJECTIVE: To assess the effectiveness of an outreach health adviser on treatment, partner notification and outcome for clients diagnosed with genital chlamydia (CT) infection at a community young people's clinic.
METHODS: From August 1999 to March 2000, a genitourinary medicine (GUM) based health adviser helped to develop testing and undertook outreach management of clients aged under 26 years diagnosed with CT infection. In addition to facilitating referral to GUM, she gave antibiotic treatment based on a GUM derived patient group direction to those not wishing to travel to the GUM clinic. She also advised them on contact tracing and the need for a compliance check (CC).
RESULTS: Chlamydia positive tests with ligase chain reaction (LCR), on first void urine, were obtained for 62 (12.9%) of 481 female clients, one (5%) of 20 male clients, and nine (53%) of 17 male contacts of female positive cases. All 72 testing positive received their result and were treated. Two urine samples positive for CT showed positive LCR tests for gonorrhoea. Proportions of named contacts seen (67%) and reattendances for compliance checks (60%) were similar to those for women seen in GUM services.
CONCLUSIONS: Health adviser input with the ability to treat can be effective in reducing the growth of identified but untreated genital chlamydia infection consequent upon community based screening. Such a strategy appears comparable with, and can add to, GUM based treatment of infection. It helps to address the need for alternative management strategies in the light of the national sexual health strategy.

Entities:  

Mesh:

Year:  2002        PMID: 12081168      PMCID: PMC1744423          DOI: 10.1136/sti.78.2.101

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  19 in total

1.  Detection or treatment: which outcome measure?

Authors:  I Simms; H Mallinson; J Hopwood; A M Webb; K Fenton; J Pimenta
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

Review 2.  Genital chlamydial infections: epidemiology and reproductive sequelae.

Authors:  W Cates; J N Wasserheit
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

3.  Evaluation of field follow-up in a sexually transmitted disease clinic for patients at risk for infection with Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  B P Katz; V A Caine; R B Jones
Journal:  Sex Transm Dis       Date:  1992 Mar-Apr       Impact factor: 2.830

4.  Decrease in incidence of women treated in hospital for acute salpingitis in Sweden.

Authors:  L Weström
Journal:  Genitourin Med       Date:  1988-02

5.  An interface of chlamydia testing by community family planning clinics and referral to hospital genitourinary medicine clinics.

Authors:  C Wilkinson; H Massil; J Evans
Journal:  Br J Fam Plann       Date:  2000-10

6.  Chlamydia trachomatis screening in young people in Merseyside.

Authors:  J Harvey; A Webb; H Mallinson
Journal:  Br J Fam Plann       Date:  2000-10

7.  Audit of outcome following positive chlamydial test results in family planning clinics in Southampton.

Authors:  F Willmott; R Tolcher
Journal:  Int J STD AIDS       Date:  2000-11       Impact factor: 1.359

8.  A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.

Authors:  M Genç; A Mårdh
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

9.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

10.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  2 in total

1.  Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay.

Authors:  S J Lavelle; K E Jones; H Mallinson; A M C Webb
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

2.  Chlamydial infection among patients attending STD and genitourinary clinics in Taiwan.

Authors:  Kow-Tong Chen; Shou-Chien Chen; Chien-Chou Chiang; Lan-Hui Li; Li-Hui Tang
Journal:  BMC Public Health       Date:  2007-06-25       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.